CN Patent

CN111904928A — 一种包含布托啡诺的可注射的药物组合物及其制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2020-11-10 · 6y expired

What this patent protects

本公开涉及一种包含布托啡诺的可注射的药物组合物及其制备方法。具体而言，本公开所述的药物组合物包含布托啡诺游离碱或其可药用盐，两亲脂质，甘油三酯和生物相容性溶剂。本公开提供的药物组合物适合肌肉注射和皮下注射，刺激性小且具有长效缓释的临床优势。

USPTO Abstract

本公开涉及一种包含布托啡诺的可注射的药物组合物及其制备方法。具体而言，本公开所述的药物组合物包含布托啡诺游离碱或其可药用盐，两亲脂质，甘油三酯和生物相容性溶剂。本公开提供的药物组合物适合肌肉注射和皮下注射，刺激性小且具有长效缓释的临床优势。

Drugs covered by this patent

Patent Metadata

Patent number
CN111904928A
Jurisdiction
CN
Classification
—
Expires
2020-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.